Literature DB >> 6177252

Actions of Gila monster venom on dispersed acini from guinea pig pancreas.

J P Raufman, R T Jensen, V E Sutliff, J J Pisano, J D Gardner.   

Abstract

Venom from Gila monster (family Helodermatidae) contains a pancreatic secretagogue. In dispersed acini from guinea pig pancreas, the venom increased enzyme secretion to the same extent as did vasoactive intestinal peptide, secretin, or PHI. The abilities of vasoactive intestinal peptide and Gila monster venom to stimulate enzyme secretion were not altered by boiling but were abolished by incubation with trypsin or chymotrypsin. Like vasoactive intestinal peptide, secretin, and PHI, the venom caused a 50- to 60-fold increase in cellular cAMP and inhibited binding of 125I-vasoactive intestinal peptide to its membrane receptors on pancreatic acini. The action of venom on enzyme secretion was inhibited by [Gln9]secretin-(5-27), a vasoactive intestinal peptide receptor antagonist, but was not altered by atropine, a cholinergic receptor antagonist, or by dibutyryl cGMP, a cholecystokinin receptor antagonist. Gila monster venom contained no immunoreactive vasoactive intestinal peptide by radioimmunoassay. These results indicate that venom from Gila monster contains a peptide that can stimulate pancreatic enzyme secretion by interacting with vasoactive intestinal peptide receptors on pancreatic acinar cells and thereby activating adenylate cyclase and increasing cellular cAMP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177252     DOI: 10.1152/ajpgi.1982.242.5.G470

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates.

Authors:  Nicholas T Bello; Matthew H Kemm; Erica M Ofeldt; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-16       Impact factor: 3.619

2.  Helodermin and islet hormone release in isolated rat pancreas.

Authors:  H C Fehmann; R Göke; B Göke; R Eissele; R Arnold
Journal:  Int J Pancreatol       Date:  1991-05

3.  Distribution and co-localization of immunoreactive helospectin with vasoactive intestinal polypeptide and peptide histidine methionine in human nasal mucosa, soft palate and larynx.

Authors:  C E Hauser-Kronberger; G W Hacker; F Sundler; J Thurner; K Albegger
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

4.  GLP-1R activation for the treatment of stroke: updating and future perspectives.

Authors:  Vladimer Darsalia; David Nathanson; Thomas Nyström; Thomas Klein; Åke Sjöholm; Cesare Patrone
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

5.  Helodermin, helospectin, and PACAP stimulate cyclic AMP formation in intact bone, isolated osteoblasts, and osteoblastic cell lines.

Authors:  U H Lerner; P Lundberg; M Ransjö; P Persson; R Håkanson
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

6.  Helodermin-like peptides in thyroid C cells: stimulation of thyroid hormone secretion and suppression of calcium incorporation into bone.

Authors:  T Grunditz; P Persson; R Håkanson; A Absood; G Böttcher; C Rerup; F Sundler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

7.  Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations.

Authors:  N-C Liang; N T Bello; T H Moran
Journal:  Int J Obes (Lond)       Date:  2012-02-07       Impact factor: 5.095

Review 8.  Structural and Functional Diversity of Animal Toxins Interacting With GPCRs.

Authors:  Anne-Cécile Van Baelen; Philippe Robin; Pascal Kessler; Arhamatoulaye Maïga; Nicolas Gilles; Denis Servent
Journal:  Front Mol Biosci       Date:  2022-02-07

Review 9.  Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors.

Authors:  Jessica Lu; Sarah J Piper; Peishen Zhao; Laurence J Miller; Denise Wootten; Patrick M Sexton
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

Review 10.  Neglected Venomous Animals and Toxins: Underrated Biotechnological Tools in Drug Development.

Authors:  Guilherme Rabelo Coelho; Daiane Laise da Silva; Emidio Beraldo-Neto; Hugo Vigerelli; Laudiceia Alves de Oliveira; Juliana Mozer Sciani; Daniel Carvalho Pimenta
Journal:  Toxins (Basel)       Date:  2021-11-29       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.